PPAR agonists (Daiichi Sankyo)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NamePPAR agonists (Daiichi Sankyo)
Drug Alias NamePPAR agonists (Sankyo)PPAR gamma agonists (Sankyo)dual PPAR alpha/gamma agonists (Sankyo)antihyperglycemics (Sankyo)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPeroxisome proliferator-activated receptor γ agonistsPeroxisome proliferator-activated receptor α agonistsInsulin sensitizers
TargetsPeroxisome proliferator-activated receptor αPeroxisome proliferator-activated receptor γ
Therapy Area/IndicationsDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSankyo Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDaiichi Sankyo Co LtdSankyo Co Ltd
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus, Type 2

Other Information

ATC CodeN/A
Related LinksN/A